Y Mabs Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $611k | 38k | 16.26 |
| 2023-12-31 | $251k | 37k | 6.82 |
| 2023-09-30 | $107k | 20k | 5.45 |
| 2023-06-30 | $143k | 21k | 6.79 |
| 2023-03-31 | $382k | 76k | 5.01 |
| 2022-09-30 | $182k | 13k | 14.45 |
| 2022-06-30 | $381k | 26k | 14.90 |
| 2022-03-31 | $1.7M | 134k | 12.70 |
| 2021-12-31 | $1.0M | 64k | 16.22 |
| 2021-09-30 | $729k | 26k | 28.54 |
| 2021-06-30 | $43k | 1.4k | 32.00 |
| 2021-03-31 | $3.0k | 105 | 28.57 |
| 2020-12-31 | $3.0k | 55 | 54.55 |
| 2020-09-30 | $1.0k | 16 | 62.50 |
| 2020-06-30 | $9.2k | 219 | 42.11 |
| 2020-03-31 | $134k | 5.1k | 26.07 |
| 2019-12-31 | $6.0k | 200 | 30.00 |
| 2019-09-30 | $395k | 16k | 25.00 |
| 2019-06-30 | $59k | 2.4k | 25.00 |
| 2019-03-31 | $39k | 1.5k | 26.48 |
| 2018-12-31 | $75k | 3.7k | 20.41 |